Organoids Market – Human Tissue and iPSC Models Support...

added blog Wellness

2026-08-21 09:20:00 -

Organoids Market – Human Tissue and iPSC Models Support Personalized Medicine

Personalized medicine is one of the most promising applications of organoid technology. Patient-derived and induced pluripotent stem-cell-derived organoids allow researchers to study individual disease characteristics and treatment responses. The market was valued at USD 1.68 billion in 2024 and is projected to reach approximately USD 17.21 billion by 2035 at a CAGR of 23.55%. Human tissue...

0 Comments 0 Shares 114 Views 0 Reviews